Remote follow-up after total knee replacement

Remote Monitoring After Total Knee Replacement

NA · Diakonhjemmet Hospital · NCT07003932

This will test whether replacing routine in-person follow-up visits with remote monitoring and video check-ups works as well and costs less for people aged 50 and older after total knee replacement for osteoarthritis.

Quick facts

PhaseNA
Study typeInterventional
Enrollment140 (estimated)
Ages50 Years and up
SexAll
SponsorDiakonhjemmet Hospital (other)
Locations1 site (Oslo, Please Select)
Trial IDNCT07003932 on ClinicalTrials.gov

What this trial studies

This randomized trial will compare remote monitoring with video consultations to routine face-to-face follow-up after primary total knee replacement for osteoarthritis. Participants aged 50 and older at Diakonhjemmet Hospital will be randomly assigned to remote follow-up, with scheduled digital questionnaires and video visits as needed, or to usual care with in-person physiotherapist visits at 2 and 12 months. The primary outcome is the proportion of OMERACT-OARSI responders at six months, and secondary outcomes include health-related quality of life, healthcare costs, patient-reported adverse events, and satisfaction. Key exclusions are revision surgery, major comorbidities, cognitive dysfunction, inflammatory joint disease, inability to use Norwegian-language digital tools, or being judged unsuitable for remote monitoring by the surgeon.

Who should consider this trial

Good fit: Ideal candidates are people aged 50 or older undergoing primary total knee replacement for osteoarthritis who can use Norwegian-language digital tools (smartphone and BankID) and do not have major comorbidities or cognitive impairment.

Not a fit: Patients having revision surgery, surgery for inflammatory arthritis or trauma, those with severe comorbidities or cognitive dysfunction, those unable to use Norwegian digital tools, or those judged unsuitable by the surgeon may not benefit from remote follow-up.

Why it matters

Potential benefit: If successful, this approach could maintain clinical outcomes while saving patients time and reducing healthcare costs by avoiding unnecessary routine clinic visits.

How similar studies have performed: Previous randomized and observational studies in orthopaedics, including hip and knee replacement, have often found telemedicine or remote follow-up can produce similar patient-reported outcomes and satisfaction, though results and cost-effectiveness vary by setting.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women, 50 years of age or older
* Reffered to total knee replacement surgery due to knee osteoarthritis

Exclusion Criteria:

* Revision of previous total knee replacement surgery
* Serious comorbidities (such as severe malignancies, severe diabetes mellitus, severe infections, uncontrollable hypertension, severe cardiovascular disease, severe respiratory disease)
* Congitive dysfunction
* Total knee replacement surgery due to trauma or inflammatory joint disease (such as psoriatic arthritis or rheumatoid arthritis)
* Unable to understand Norwegian
* Low digital competency/ cannot answer questionnaires digitally (lack BankID, do not possess a smartphone)
* Deemed inappropriate for remote monitoring by orthopedic surgeon

Where this trial is running

Oslo, Please Select

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Knee Arthroplasty, Total, knee arthroplasty, remote follow-up, non-inferiority

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.